Dietary glycine supplementation reduces blood vessels in a fibrin Z-chamber assay and tumor angiogenesis in a tumor Z-chamber (fibrin with R3230 mammary adenocarcinoma cells) through the reduction of iNOS expression [91]. The gene discussed is NOS2; the disease is neoplasm.